SCHEMBL25403170

SCHEMBL25403170

Cc1ccc(CN2CC[C@@H](CN)C2)cc1

nearest known ligand 0.54

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.54
ACHE P22303 2/20 0.51
BACE1 P56817 2/20 0.51
BCHE P06276 2/20 0.51
ALDH1A1 P00352 1/20 0.49
LMNA P02545 1/20 0.49
POLB P06746 1/20 0.49
CXCR4 P61073 2/20 0.46
HRH1 P35367 1/20 0.46
KCNH2 Q12809 1/20 0.45
CACNA1I Q9P0X4 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25404886 1.00 TP53 (0.54) TP53ACHEBACE1BCHEALDH1A1
Hydrochloric Acid SCHEMBL25402582 0.98 TP53 (0.53) TP53ACHEBACE1BCHEALDH1A1
SCHEMBL14398343 0.90 ALDH1A1 (0.56) ACHEBACE1ALDH1A1LMNAPOLB
SCHEMBL4847846 0.85 ALDH1A1 (0.56) TP53ACHEBACE1BCHEALDH1A1
SCHEMBL22254431 0.85 ALDH1A1 (0.54) TP53ACHEBACE1BCHEALDH1A1
SCHEMBL16122102 0.84 CYP2D6 (0.57) TP53ACHEBACE1BCHEALDH1A1
SCHEMBL242758 0.83 CCR3 (0.62) ACHEBACE1BCHEALDH1A1CXCR4
SCHEMBL1180490 0.83 CCR3 (0.62) ACHEBACE1BCHEALDH1A1CXCR4
SCHEMBL3074896 0.83 CCR3 (0.62) ACHEBACE1BCHEALDH1A1CXCR4
SCHEMBL3172847 0.81 CYP2D6 (0.62) ALDH1A1POLBCXCR4KCNH2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4463452-A2 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER Anima Biotech Inc. (US) 2024-11-20 EP disclosed
WO-2023177700-A2 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER ANIMA BIOTECH INC. (US) 2023-09-21 WO disclosed